Published in Nucl Med Biol on August 01, 1996
Extrapulmonary effects of inhaled nitric oxide: role of reversible S-nitrosylation of erythrocytic hemoglobin. Proc Am Thorac Soc (2006) 1.15
S-nitrosothiol repletion by an inhaled gas regulates pulmonary function. Proc Natl Acad Sci U S A (2001) 1.11
[11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology (2006) 12.10
Brain blood flow measured with intravenous H2(15)O. II. Implementation and validation. J Nucl Med (1983) 5.39
The acute respiratory distress syndrome. N Engl J Med (1995) 5.24
Brain blood flow measured with intravenous H2(15)O. I. Theory and error analysis. J Nucl Med (1983) 4.72
Improved outcome based on fluid management in critically ill patients requiring pulmonary artery catheterization. Am Rev Respir Dis (1992) 3.64
Efficient production of high specific activity 64Cu using a biomedical cyclotron. Nucl Med Biol (1997) 3.25
A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol (1984) 3.11
Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet (1997) 2.88
Bioactive cardiac substances: potent vasorelaxant activity in mammalian atria. Science (1983) 2.53
In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. Bioconjug Chem (2000) 2.30
Metabolic flare: indicator of hormone responsiveness in advanced breast cancer. J Clin Oncol (2001) 2.20
A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys (2001) 2.15
Fluid balance during pulmonary edema. Is fluid gain a marker or a cause of poor outcome? Chest (1991) 2.03
Radiometal-labeled agents (non-technetium) for diagnostic imaging. Chem Rev (1999) 1.93
Increased frequency of rheumatoid factor precursor B lymphocytes after immunization of normal adults with tetanus toxoid. Clin Exp Immunol (1983) 1.88
Indium-111-labeled leukocytes for the localization of abscesses: preparation, analysis, tissue distribution, and comparison with gallium-67 citrate in dogs. J Lab Clin Med (1977) 1.87
Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med (1982) 1.85
Clinical evaluation compared to pulmonary artery catheterization in the hemodynamic assessment of critically ill patients. Crit Care Med (1984) 1.76
Functional consequences of posttranslational isomerization of Ser46 in a calcium channel toxin. Science (1994) 1.73
Metabolism in immunoreactive parathyroid hormone in the dog. The role of the kidney and the effects of chronic renal disease. J Clin Invest (1975) 1.70
High-resolution microPET imaging of carcinoembryonic antigen-positive xenografts by using a copper-64-labeled engineered antibody fragment. Proc Natl Acad Sci U S A (2000) 1.69
Ethnic differences in secretion, sensitivity, and hepatic extraction of insulin in black and white Americans. Diabet Med (1994) 1.67
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. J Nucl Med (1999) 1.62
Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res (1976) 1.61
Noninvasive quantitation of myocardial blood flow in human subjects with oxygen-15-labeled water and positron emission tomography. J Am Coll Cardiol (1989) 1.56
Intracellular metabolism of indium-111-DTPA-labeled receptor targeted proteins. J Nucl Med (1993) 1.56
Relationship between lipophilicity and brain extraction of C-11-labeled radiopharmaceuticals. J Nucl Med (1983) 1.55
Breast cancer: PET imaging of estrogen receptors. Radiology (1988) 1.53
A prospective study of lung water measurements during patient management in an intensive care unit. Am Rev Respir Dis (1987) 1.52
The in vivo behavior of copper-64-labeled azamacrocyclic complexes. Nucl Med Biol (1998) 1.52
Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation. J Nucl Med (2001) 1.51
Positron emission tomographic assessment of "metabolic flare" to predict response of metastatic breast cancer to antiestrogen therapy. Eur J Nucl Med (1999) 1.49
MPTP-induced up-regulation of in vivo dopaminergic radioligand-receptor binding in humans. Neurology (1987) 1.49
Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Science (1985) 1.48
Blood-brain barrier permeability of 11C-labeled alcohols and 15O-labeled water. Am J Physiol (1976) 1.48
Feasibility of time-of-flight reconstruction in positron emission tomography. J Nucl Med (1980) 1.48
In vivo comparison of copper blood-pool agents: potential radiopharmaceuticals for use with copper-62. J Nucl Med (1991) 1.46
Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia. J Neurosci (1997) 1.43
In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: a potential approach for identification of jeopardized myocardium. J Am Coll Cardiol (1990) 1.42
Ventilator-associated pneumonia: clinical considerations. AJR Am J Roentgenol (1994) 1.41
Diagnostic implications of spectral and temporal analysis of the entire cardiac cycle in patients with ventricular tachycardia. Circulation (1991) 1.41
Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol (2001) 1.39
Preparation and evaluation of 111In-labeled leukocytes as an abscess imaging agent in dogs. Radiology (1976) 1.36
Positron emission tomography with 2-[18F]Fluoro-2-deoxy-D-glucose and 16alpha-[18F]fluoro-17beta-estradiol in breast cancer: correlation with estrogen receptor status and response to systemic therapy. Clin Cancer Res (1996) 1.35
Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. J Nucl Med (1995) 1.34
Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy. Am J Med (1983) 1.33
Copper-64-labeled antibodies for PET imaging. J Nucl Med (1992) 1.29
Homodimeric and heterodimeric bis(amino thiol) oxometal complexes with rhenium(V) and technetium(V). Control of heterodimeric complex formation and an approach to metal complexes that mimic steroid hormones. J Med Chem (1994) 1.29
Quantification of regional myocardial blood flow in vivo with H215O. Circulation (1984) 1.24
Vocal cord dysfunction in a child with asthma. J Asthma (1991) 1.23
Pulmonary deposition of aerosols in children with cystic fibrosis. J Pediatr (1974) 1.22
RadioimmunoPET: detection of colorectal carcinoma with positron-emitting copper-64-labeled monoclonal antibody. J Nucl Med (1995) 1.21
Positron tomographic assessment of 16 alpha-[18F] fluoro-17 beta-estradiol uptake in metastatic breast carcinoma. J Nucl Med (1991) 1.21
Radioimmunotherapy with a 64Cu-labeled monoclonal antibody: a comparison with 67Cu. Proc Natl Acad Sci U S A (1996) 1.20
Enzyme replacement therapy for murine mucopolysaccharidosis type VII leads to improvements in behavior and auditory function. J Clin Invest (1998) 1.20
Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med (1984) 1.18
Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets. Lancet (1978) 1.17
The measure in vivo of regional cerebral oxygen utilization by means of oxyhemoglobin labeled with radioactive oxygen-15. J Clin Invest (1970) 1.17
Positron emission tomographic measurement of cerebral blood flow and permeability-surface area product of water using [15O]water and [11C]butanol. J Cereb Blood Flow Metab (1987) 1.16
Quantitation of myocardial fatty acid metabolism using PET. J Nucl Med (1996) 1.15
High purity production and potential applications of copper-60 and copper-61. Nucl Med Biol (1999) 1.15
Prophylactic therapy for stress ulcer bleeding: a reappraisal. Ann Intern Med (1987) 1.15
Photon time-of-flight-assisted positron emission tomography. J Comput Assist Tomogr (1981) 1.14
The measurement of regional ventilation in man: a new method of quantitation. J Nucl Med (1973) 1.13
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes (2001) 1.13
Indium-111-labeled cellular blood components: mechanism of labeling and intracellular location in human neutrophils. J Nucl Med (1977) 1.10
NCA 16 alpha-[18F]fluoroestradiol-17 beta: the effect of reaction vessel on fluorine-18 resolubilization, product yield, and effective specific activity. Int J Rad Appl Instrum A (1986) 1.10
Effects of tea tree oil on Escherichia coli. Lett Appl Microbiol (1998) 1.09
Role of cyclooxygenase-2 in oleic acid-induced acute lung injury. Am J Respir Crit Care Med (1999) 1.08
Preparation of four fluorine- 18-labeled estrogens and their selective uptakes in target tissues of immature rats. J Nucl Med (1984) 1.08
Tomographic images of blood pool and perfusion in brain and heart. J Nucl Med (1976) 1.08
Inhaled steroids and severe viral infections. J Asthma (1994) 1.07
Pill swallowing ability and training in children 6 to 11 years of age. Clin Pediatr (Phila) (2006) 1.06
Comparison of four bifunctional chelates for radiolabeling monoclonal antibodies with copper radioisotopes: biodistribution and metabolism. Bioconjug Chem (1997) 1.06
Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells. Ann Nucl Med (2001) 1.06
Small animal imaging. current technology and perspectives for oncological imaging. Eur J Cancer (2002) 1.05
Preclinical evaluation of fluorine-18-labeled androgen receptor ligands in baboons. J Nucl Med (1996) 1.05
Radiotoxicity of 5-[123I]iodo-2'-deoxyuridine in V79 cells: a comparison with 5-[125I]iodo-2'-deoxyuridine. Radiat Res (1989) 1.05
In vitro and in vivo evaluation of copper-64-octreotide conjugates. J Nucl Med (1995) 1.04
Implementation and evaluation of a two-compartment model for quantification of myocardial perfusion with rubidium-82 and positron emission tomography. Circ Res (1992) 1.04
Determination of octanol-water partition coefficient for terpenoids using reversed-phase high-performance liquid chromatography. J Chromatogr A (1999) 1.03
Acute Pneumonitis-an Atypical Bronchopneumonia of virus Origin. Can Med Assoc J (1942) 1.03
PET imaging of hypoxia. Q J Nucl Med (2001) 1.03
Evaluation of 62Cu labeled diacetyl-bis(N4-methylthiosemicarbazone) as a hypoxic tissue tracer in patients with lung cancer. Ann Nucl Med (2000) 1.01
Tracer-kinetic models for measuring cerebral blood flow using externally detected radiotracers. J Cereb Blood Flow Metab (1987) 1.01
Differences in the sites of iodination of proteins following four methods of radioiodination. Biochim Biophys Acta (1977) 1.01
The determination of regional cerebral blood flow by means of water labeled with radioactive oxygen 15. Radiology (1969) 1.01
Early metabolic improvement following bariatric surgery in morbidly obese adolescents. Pediatr Blood Cancer (2011) 1.01
Lethality of Auger electrons from the decay of bromine-77 in the DNA of mammalian cells. Radiat Res (1982) 1.01
Noninvasive quantification of regional myocardial perfusion with rubidium-82 and positron emission tomography. Exploration of a mathematical model. Circulation (1990) 1.00
Fluorine-18 labeling of proteins. J Nucl Med (1987) 1.00
Scintigraphic detection of carotid atherosclerosis with indium-111-labeled autologous platelets. Circulation (1980) 1.00
Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion. J Nucl Med (1990) 0.99
Experimental fecal transmission of human cryptosporidia to pigs, and attempted treatment with an ornithine decarboxylase inhibitor. Vet Pathol (1982) 0.99
Isolated absence of nasal cilia: a case report. Ann Allergy (1984) 0.99